Day: August 17, 2020

UNIONDALE and ISLANDIA, N.Y., Aug. 17, 2020 (GLOBE NEWSWIRE) — Today, John R. Buran, President and Chief Executive Officer of Flushing Financial Corporation (“Flushing”) (Nasdaq-GS:FFIC) announced, “I am pleased that our respective Boards have agreed to extend the timeframe for Flushing to complete the acquisition of Empire Bancorp Inc. (“Empire”) (OTC:EMPK), and we are now anticipating a fourth quarter close.“With this acquisition, we will create a community bank of superior scale and operational leverage that presents us with a greater ability to improve service to our customers and enhance shareholder value. The acquisition of Empire is consistent with our stated strategic objectives. This acquisition will reduce our cost of funds and increase our non-interest bearing deposits. It will make us more efficient in both the short...

TAMPA, Fla., Aug. 17, 2020 (GLOBE NEWSWIRE) — Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a deep-ocean exploration pioneer engaged in the discovery, development and extraction of deep-ocean minerals, reported results for the second quarter ended June 30, 2020, and provided an update on current company operations and projects.Odyssey’s key focus during the quarter continued to be the Exploraciones Oceanicas (ExO) phosphate project in Mexico. This project could provide access to a critical resource needed to produce fertilizer, helping to provide food security to the Mexican people and supplying the phosphate needs of North America for at least 50 years.Odyssey’s legal teams are working two separate, but concurrent processes, while Odyssey continues to work through diplomatic channels in attempts to reach a mutually beneficial...

FDA sets target action date of June 1, 2021BASEL, Switzerland, Aug. 17, 2020 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced that its New Drug Application (NDA) for once-daily, oral relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) for the treatment of women with heavy menstrual bleeding associated with uterine fibroids has been accepted for review by the U.S. Food and Drug Administration (FDA).“Relugolix is now under FDA review for two distinct potential new treatment options in uterine fibroids and advanced prostate cancer, indications with high unmet need where we have the opportunity to elevate the standard of care for women and for men,” said Lynn Seely, M.D., chief executive officer of Myovant...

Company Aims to Expand its Footprint to International Markets on the African ContinentNEW YORK, Aug. 17, 2020 (GLOBE NEWSWIRE) — Datasea Inc. (NASDAQ: DTSS) (“Datasea” or the “Company”), a technology company engaged in providing smart security solutions and developing education-related technologies in China, has, through one of its variable interest entities, entered into a Cooperation Framework Agreement with China Africa Friendship Town Investment Group Limited (“CAFTI”) to establish a general framework and promote Datasea’s products across several countries in Africa.As a Ugandan-based and registered limited company, CAFTI specializes in industrial park investments and construction, IT services, as well as import and export trades across Africa, and has developed a network of contacts across the continent, including, Uganda,...

LONDON, Aug. 17, 2020 (GLOBE NEWSWIRE) — Horizonte Minerals Plc (the “Company” or “Horizonte”) (AIM: HZM; TSX: HZM), the nickel development company focused in Brazil, is pleased to announce that it has today published its 2019 Sustainability Report. The report is an overview of the Company’s sustainability performance over the 2019 financial year and is primarily focussed on the Araguaia ferronickel project but, data from the Vermelho nickel-cobalt project and corporate head office is included where appropriate.The report is available to view on the Company’s website at: https://horizonteminerals.com/uk/en/sustainability_report/This is the first standalone Sustainability Report that Horizonte has published as the Company recognises the importance of conveying its efforts and achievements around the areas of environmental...

NEW YORK, Aug. 17, 2020 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or “Company”) (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: 0VZ) today announces its intention to amend the term and exercise price of the 6,085,192 Class A subordinate voting share purchase warrants (the “Warrants”) issued as part of the Company’s private placement which closed on February 10, 2020.Under the current terms, each Warrant can be exercised to acquire one Class A subordinate voting share of Acreage (each, a “Warrant Share”) until 4:00 p.m. on February 10, 2025 at an exercise price of US$5.80 per Warrant Share. Subject to all conditions to the Amended Arrangement (as hereinafter defined) being satisfied (to the extent capable of being satisfied at the relevant time), the Company intends to modify the exercise price of the Warrants to US$4.00 per Warrant...

SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced the clearance of the pivotal ENVASARC protocol after filing the protocol with the U.S. Food and Drug Administration (FDA) as part of an Investigational New Drug (IND) application on July 15. The application cross referenced the open envafolimab IND maintained by TRACON’s corporate partners 3D Medicines and Alphamab Oncology. TRACON expects to initiate enrollment in the ENVASARC trial at 25 sites in the U.S. in the fourth quarter of 2020.“We...

SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (the “Company”) (Nasdaq: ONVO) today announced that it filed a certificate of second amendment to its certificate of incorporation with the Secretary of State of the State of Delaware to effect a 1-for-20 reverse stock split of its common stock. The shares underlying the Company’s outstanding options and restricted stock unit awards will also be adjusted accordingly. The reverse stock split will take effect at 5:00 pm (Eastern Time) on August 18, 2020, and the Company’s common stock will open for trading on The Nasdaq Capital Market on August 19, 2020 on a post-split basis.At the Company’s Special Meeting of Stockholders held on March 26, 2020, the Company’s stockholders approved a reverse stock split within a range of 1-for 20 and 1-for-40. The specific ratio of...

Management reportConsolidated net sales for Q2 2020 were € 2.48 million from continuing operations (Q2 2019: € 3.48 million from continuing operations). The sales revenue of the Group`s main business segment, fibreboard, for Q2 2020 were € 2.43 million (Q2 2019: € 3.01 million). The main reason for this drop in sales was due to the closure of the Püssi factory in March 2020, which came about as a result of the loss of orders from customers within the display board industry caused by the COVID-19 pandemic. Furniture retail sales revenue for Q2 2020 were € 8 thousand, the decrease in sales (compared to Q2 2019: € 468 thousand) was due to the Group exiting the furniture retail segment earlier this year, with some remaining stock sales taking place during Q2 2020. Rental and property development sales, includes the resale of utilities, in...

JUHTKONNA ARUANNENordic Fibreboard AS konsolideeritud müügitulu oli 2020. aasta 2. kvartalis jätkuvatelt tegevustelt 3,48 miljonit eurot (2019 2. kvartalis jätkuvatelt tegevustelt 3,48 miljonit eurot). Kontserni peamise ärisegmendi, puitkiudplaadi, müügitulu 2020. aasta 2. kvartalis oli 2,43 miljonit eurot (2019 2. kvartalis 3,01 miljonit eurot). Müügitulu languse peamiseks põhjuseks oli  Püssi tehase sulgemine 2020. aasta märtsis, mis tulenes COVID-19 pandeemia tõttu klientide tellimuste olulistest kaotustest märkmetahvlite tööstuses. Mööbli jaemüügi müügitulu 2020. aasta 2. kvartalis 8 tuhat eurot, müügitulu vähenemine (võrreldes 2019. aasta 2. kvartaliga 468 tuhat eurot) tulenes Kontserni väljumisest mööbli jaemüügi segmendist selle aasta alguses ning 2020. aasta 2. kvartalis alguses toimus ainult mõnede järelejäänud laojääkide tühjendusmüük....